Chart: Petition May Reach Beyond Weight-Loss Claims
This article was originally published in The Tan Sheet
Executive Summary
One of several reasons FDA might not act immediately, if at all, on a petition to consider dietary supplement weight-loss claims as disease claims is the process could affect a broader portion of the supplement market than weight-management products.You may also be interested in...
People In Brief
In Brief
Supplement GMP Warning Letters Make Modest Debut In 2010
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: